Investigating the value of pre-treatment 18F-FDG PET/CT in predicting the pathological characteristic of hepatocellular carcinoma and recurrence after liver transplantation

Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation

(2019) Yeon-koo Kang et al.   EUROPEAN RADIOLOGY

FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study

(2019) Louis Leong-Liung Ling et al.   International Journal of Surgery

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma

(2018) Chetana Lim et al.   HPB

Role of [ 18 F] fludeoxyglucose positron emission tomography in the selection of liver transplantation candidates in patients with hepatocellular carcinoma

(2017) Yu-Fu Ye et al.   Hepatobiliary & Pancreatic Diseases International

Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study

(2017) Yasutsugu Takada et al.   Journal of Hepato-Biliary-Pancreatic Sciences

18F-FDG PET in Liver Transplantation Setting of Hepatocellular Carcinoma

(2016) Matthieu Bailly et al.   CLINICAL NUCLEAR MEDICINE

Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantation

(2016) Soo-Ho Lee et al.   CLINICAL TRANSPLANTATION

Alpha-fetoprotein and 18F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation

(2016) Geun Hong et al.   JOURNAL OF HEPATOLOGY

Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET/CT

(2016) Y.-i. Kim et al.   JOURNAL OF NUCLEAR MEDICINE

Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation

(2016) Chien-Chin Hsu et al.   TRANSPLANTATION

Role of positron emission tomography/computed tomography in living donor liver transplantation for hepatocellular carcinoma

(2016) Seung Duk Lee et al.   HEPATOBILIARY SURGERY AND NUTRITION

[18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma

(2015) Yael Asman et al.   LIVER TRANSPLANTATION

Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis

(2013) Linda L. Wong et al.   CLINICAL TRANSPLANTATION

Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge

(2012) Martin-Walter Welker et al.   TRANSPLANT INTERNATIONAL

Patients with non-[18F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation

(2011) Arno Kornberg et al.   LIVER TRANSPLANTATION

Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China

(2009) Jia Fan et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Prediction of Tumor Recurrence by 18F-FDG PET in Liver Transplantation for Hepatocellular Carcinoma

(2009) J. W. Lee et al.   JOURNAL OF NUCLEAR MEDICINE